Old West Investment Management LLC Makes New $698,000 Investment in Core Laboratories Inc. $CLB

Old West Investment Management LLC acquired a new stake in Core Laboratories Inc. (NYSE:CLB) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 59,910 shares of the oil and gas company’s stock, valued at approximately $698,000.

Other institutional investors have also recently modified their holdings of the company. Goldman Sachs Group Inc. grew its holdings in shares of Core Laboratories by 185.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company’s stock worth $13,549,000 after purchasing an additional 548,657 shares in the last quarter. Disciplined Growth Investors Inc. MN raised its stake in Core Laboratories by 9.7% in the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after purchasing an additional 528,976 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Core Laboratories in the second quarter valued at about $4,675,000. MAC Alpha Capital Management LP acquired a new position in Core Laboratories in the fourth quarter valued at about $5,016,000. Finally, Heartland Advisors Inc. bought a new stake in Core Laboratories during the first quarter worth about $2,518,000. 97.81% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Weiss Ratings upgraded shares of Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, August 3rd. Johnson Rice upgraded shares of Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 target price for the company in a research report on Thursday. Finally, Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Saturday, August 1st. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Core Laboratories currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

Core Laboratories Trading Up 0.2%

Shares of CLB stock opened at $12.48 on Monday. Core Laboratories Inc. has a fifty-two week low of $9.79 and a fifty-two week high of $20.36. The stock’s fifty day moving average price is $11.60 and its two-hundred day moving average price is $14.67. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.55 and a current ratio of 2.12. The company has a market cap of $572.54 million, a PE ratio of 22.28, a P/E/G ratio of 3.00 and a beta of 1.03.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%.The company had revenue of $124.61 million during the quarter, compared to analysts’ expectations of $126.26 million. During the same quarter in the previous year, the firm earned $0.19 EPS. Core Laboratories’s revenue was down 4.3% on a year-over-year basis. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Equities analysts predict that Core Laboratories Inc. will post 0.53 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 10th will be given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, August 10th. Core Laboratories’s payout ratio is currently 7.14%.

Insider Buying and Selling

In other Core Laboratories news, CEO Lawrence Bruno bought 5,000 shares of the stock in a transaction on Friday, July 31st. The stock was purchased at an average price of $10.78 per share, with a total value of $53,900.00. Following the completion of the purchase, the chief executive officer owned 262,438 shares in the company, valued at $2,829,081.64. The trade was a 1.94% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.26% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.